Tabel 1 angiver bivirkninger rapporteret hos 153 patienter behandlet med Replagal i kliniske studier, herunder 21 patienter med tidligere tilfælde af nyresygdom i sidste stadie og 17 kvindelige patienter.
Table 1 lists adverse drug reactions (ADRs) reported for the 153 patients treated with Replagal in clinical trials, including 21 patients with history of endstage renal disease and 17 female patients.